Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/1998
04/16/1998WO1998015575A1 Promoter for smooth muscle cell expression
04/16/1998WO1998015574A1 Methods and compositions for generating angiostatin
04/16/1998WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery
04/16/1998WO1998011229A3 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
04/16/1998WO1998007876A3 Self-replicating episomal expression vectors conferring tissue-specific gene expression
04/16/1998CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery
04/16/1998CA2268353A1 Alphavirus-retrovirus vectors
04/16/1998CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells
04/16/1998CA2267187A1 Method for preparing compositions for transferring nucleic acids
04/16/1998CA2267067A1 Promoter for smooth muscle cell expression
04/16/1998CA2266466A1 Mammary gland-specific promoters
04/16/1998CA2265550A1 Methods and compositions for generating angiostatin
04/15/1998EP0835938A2 Topoisomerase I
04/15/1998EP0835937A2 Human MYT-1 kinase clone
04/15/1998EP0835936A2 Arginyl tRNA synthase
04/15/1998EP0835933A2 A G-protein coupled receptor, HLTEX11
04/15/1998EP0835321A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
04/15/1998EP0835320A1 Improved retroviral vectors, especially suitable for gene therapy
04/15/1998EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1
04/15/1998EP0835309A2 Vaccine for infectious agents, composition for treating and preventing hiv infections
04/15/1998EP0835308A1 Bax omega protein and methods
04/15/1998EP0835264A1 Human g-protein receptor hcegh45
04/15/1998EP0835261A1 Ion channel
04/15/1998EP0835238A1 New cationic and polycationic amphiphiles, reactives containing the same and their use
04/15/1998EP0835137A1 Encapsulated cells producing viral particles
04/15/1998EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
04/15/1998CN1179179A Recombinant human immunodeficiency virus-producing cell
04/15/1998CN1178797A Oligopeptide derivative containing alpha, gamma-diaminobutanoic acid
04/14/1998US5739307 Cell growth factors
04/14/1998US5739118 Compositions and methods for delivery of genetic material
04/14/1998US5739009 Adipocyte-specific differentiation-related protein
04/14/1998US5738985 Screening for potential antiviral agent by determining whether a potential antiviral agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus rna
04/09/1998WO1998014596A2 Disease associated protein tyrosine phosphatases
04/09/1998WO1998014593A2 Human telomerase catalytic subunit
04/09/1998WO1998014592A2 Telomerase reverse transcriptase
04/09/1998WO1998014586A1 A polynucleotide herpes virus vaccine
04/09/1998WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)
04/09/1998WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
04/09/1998WO1998014577A3 Nucleotide and protein sequence of mammastatin and methods of use
04/09/1998WO1998014577A2 Nucleotide and protein sequence of mammastatin and methods of use
04/09/1998WO1998014576A2 Secreted proteins and polynucleotides encoding them
04/09/1998WO1998014572A1 Novel human phospholemman-like protein
04/09/1998WO1998014569A1 Leukocyte-specific protein and gene, and methods of use thereof
04/09/1998WO1998014568A1 Human growth gene and short stature gene region
04/09/1998WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES
04/09/1998WO1998014562A1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity
04/09/1998WO1998014462A1 cDNA FOR FANCONI ANEMIA COMPLEMENTATION GROUP A
04/09/1998WO1998014461A1 NOVEL spsB
04/09/1998WO1998014439A1 Piperazine based cytofectins
04/09/1998WO1998014217A1 Methods and means for the treatment of malignancies
04/09/1998WO1998014210A1 Method for treating allergic lung disease
04/09/1998WO1998014197A1 Method of inhibiting smooth muscle cell proliferation
04/09/1998WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
04/09/1998WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
04/09/1998WO1997045550A3 Mini-adenoviral vector
04/09/1998WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
04/09/1998DE19701141C1 Gene construct for treatment of disease involving protease, particularly tumours and inflammation
04/09/1998DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use
04/09/1998CA2647169A1 Human growth gene and short stature gene region
04/09/1998CA2645721A1 Human telomerase reverse transcriptase
04/09/1998CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
04/09/1998CA2267694A1 Method of inhibiting smooth muscle cell proliferation
04/09/1998CA2267675A1 Method for treating allergic lung disease
04/09/1998CA2267664A1 Human telomerase reverse transcriptase
04/09/1998CA2267645A1 A polynucleotide herpes virus vaccine
04/09/1998CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)
04/09/1998CA2267097A1 Human growth gene and short stature gene region
04/09/1998CA2266752A1 Telomerase reverse transcriptase
04/09/1998CA2265449A1 Disease associated protein tyrosine phosphatases
04/09/1998CA2265447A1 Novel human phospholemman-like protein
04/08/1998EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives
04/08/1998EP0834568A2 Novel saliva binding protein
04/08/1998EP0834565A2 A G-protein coupled receptor HUVCT36
04/08/1998EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33
04/08/1998EP0834560A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof
04/08/1998EP0834323A1 Cytokine gene therapy for treatment of malignacies
04/08/1998EP0833948A1 Colon specific gene and protein
04/08/1998EP0833935A1 Cell line producing analgesic compounds for treating pain
04/08/1998EP0833934A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
04/08/1998EP0833924A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation
04/08/1998EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY
04/08/1998EP0833920A2 Transferrin receptor genes
04/08/1998EP0833916A1 Decorin binding protein compositions and methods of use
04/08/1998EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1
04/08/1998EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
04/08/1998EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors
04/08/1998EP0833904A1 Fibroblast growth factor-14
04/08/1998EP0833896A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses
04/08/1998EP0833892A1 Human hepatoma-derived growth factor-2
04/08/1998EP0833840A1 Hypoxia inducible factor-1 and method of use
04/08/1998EP0833668A1 Inhibition of hepatitis b replication
04/08/1998EP0833667A1 Stabilization of polynucleotide complexes
04/08/1998EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment
04/08/1998EP0833660A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
04/08/1998EP0833613A1 Delivery vehicles comprising stable lipid/nucleic acid complexes
04/08/1998CN1178555A Gene recombinant
04/08/1998CN1178534A Isolated nucleic acid molecules as members of the Mage-Xp family and uses thereof
04/07/1998US5736524 Polynucleotide tuberculosis vaccine
04/07/1998US5736395 Transforming cells in mammal by contacting with complexes comprising an expression cassette and a nitrogen-containing amphiphile
04/07/1998US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex
1 ... 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 ... 870